Mizuho reaffirmed their neutral rating on shares of EQT (NYSE:EQT – Free Report) in a research report sent to investors on Thursday, Benzinga reports. Mizuho currently has a $39.00 price target on the oil and gas producer’s stock. EQT has been the subject of several other reports. The Goldman Sachs Group cut their target price […]
EQT (NYSE:EQT – Free Report) had its price target lifted by Jefferies Financial Group from $42.00 to $43.00 in a research report released on Friday morning, Benzinga reports. Jefferies Financial Group currently has a buy rating on the oil and gas producer’s stock. Other analysts have also issued reports about the company. JPMorgan Chase & […]
Five major global private equity firms - Warburg Pincus, Permira, EQT, Bain, and TPG - are interested in acquiring Bharat Serums and Vaccines (BSV) as the company's current owners seek a valuation exceeding ..
Five global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Vaccines (BSV), which is seeking over $1 billion. The firms will sign expressions of interest soon and start due diligence on the Mumbai-based biopharmaceutical company. Advent International, the current owner, acquired BSV in 2019 and now wants to sell it. Some contenders may partner with pharmaceutical companies for the bid. Advent has engaged Jefferies and JP Morgan for the sale process.
Private equity firm OrbiMed and British International Investment (BII) and are looking to sell their entire stake in an Indian healthcare company through a secondary ..